Methacrylic Acid

Methacrylic Acid

SCHEMBL3248312

C=C(C)C(=O)O.C=C(C)C(=O)O.C=C(C)C(=O)O.Cl.[Cr]

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Methacrylic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
LCK known ✓ P06239 1/20 0.43
TDP1 Q9NUW8 2/20 0.47
FFAR3 O14843 1/20 0.43
FYN P06241 1/20 0.43
ALDH1A1 P00352 3/20 0.40
LMNA P02545 2/20 0.36
HSD17B10 Q99714 1/20 0.35
TSHR P16473 2/20 0.33
THPO P40225 1/20 0.33
TGFBR1 P36897 1/20 0.32
CA1 P00915 1/20 0.31
ALOX15 P16050 1/20 0.31
BLM P54132 1/20 0.31
PMP22 Q01453 1/20 0.31
KDM4E B2RXH2 1/20 0.31
TET2 Q6N021 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methacrylic Acid SCHEMBL9547394 1.00 TDP1 (0.47) TDP1FFAR3LCKFYNALDH1A1
Methacrylic Acid SCHEMBL29139959 1.00 TDP1 (0.47) TDP1FFAR3LCKFYNALDH1A1
Methacrylic Acid SCHEMBL28599121 1.00 TDP1 (0.47) TDP1FFAR3LCKFYNALDH1A1
Methacrylic Acid SCHEMBL7894642 1.00
Methacrylic Acid SCHEMBL674552 0.96
Methacrylic Acid SCHEMBL28828740 0.96 TDP1 (0.50) TDP1FFAR3LCKFYNALDH1A1
Methacrylic Acid SCHEMBL9420287 0.96 TDP1 (0.50) TDP1FFAR3LCKFYNALDH1A1
Methacrylic Acid SCHEMBL15637905 0.96
Methacrylic Acid SCHEMBL11401200 0.96 TDP1 (0.50) TDP1FFAR3LCKFYNALDH1A1
Methacrylic Acid SCHEMBL28913569 0.96 TDP1 (0.50) TDP1FFAR3LCKFYNALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0104516-B1 NACREOUS PIGMENTS MERCK PATENT GmbH (DE) 1988-03-30 EP claimed
US-4482389-A Nacreous pigments MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1984-11-13 US claimed
EP-2089478-B1 SURFACE-MODIFIED (EFFECT) PIGMENTS BASF SE (DE) 2016-01-27 EP disclosed
US-7897306-B2 Substrate provided with bank and substrate provided with color pattern TOPPAN PRINTING CO., LTD. (JP) 2011-03-01 US disclosed
US-20100178308-A1 SURFACE-MODIFIED (EFFECT) PIGMENTS CIBA CORPORATION (US) 2010-07-15 US disclosed
EP-2089478-A1 SURFACE-MODIFIED (EFFECT) PIGMENTS Ciba Holding Inc. (CH) 2009-08-19 EP disclosed
US-20090176916-A1 RUBBER COMPOSITION AND VIBRATION-PROOF MATERIAL SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
US-20090053625-A1 Substrate provided with bank and substrate provided with color pattern TOPPAN PRINTING CO. LTD. (JP) 2009-02-26 US disclosed
WO-2008068152-A1 SURFACE-MODIFIED (EFFECT) PIGMENTS CIBA HOLDING INC. (CH) 2008-06-12 WO disclosed
US-5428098-A Chemically uniform copolymer of polycycloolefin-monocycloolefin and acyclic olefin; weatherproofing, rigidity, low water absorption, and heat resistance HOECHST AKTIENGESELLSCHAFT (DE) 1995-06-27 US disclosed
US-4482389-A Nacreous pigments MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1984-11-13 US disclosed
US-4482389-A Nacreous pigments MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1984-11-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100178308-A1 SURFACE-MODIFIED (EFFECT) PIGMENTS MYH14, PHOSPHO1, MYO3A LCK 3516/4885TDP1 1069/4885FFAR3 3277/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.